Tiwari U, Akhtar S, Mir S, Khan M
Mol Divers. 2025; .
PMID: 39899124
DOI: 10.1007/s11030-025-11122-9.
Biziukova N, Rudik A, Dmitriev A, Tarasova O, Filimonov D, Poroikov V
ACS Omega. 2025; 10(3):2459-2471.
PMID: 39895765
PMC: 11780559.
DOI: 10.1021/acsomega.4c05723.
Mirakhori F, Niazi S
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861110
PMC: 11769376.
DOI: 10.3390/ph18010047.
Molla M, Aljahdali M
Discov Oncol. 2024; 15(1):814.
PMID: 39704776
PMC: 11662097.
DOI: 10.1007/s12672-024-01711-9.
Attwa M, Abdelhameed A, Kadi A
Medicina (Kaunas). 2024; 60(10).
PMID: 39459413
PMC: 11509458.
DOI: 10.3390/medicina60101626.
Assessment of the metabolic stability of CEP-37440, a selective FAK/ALK inhibitor, in HLMs using fast UPLC-MS/MS method: metabolic lability and DEREK alerts screening.
Attwa M, Alrabiah H, Abdelhameed A, Kadi A
Front Chem. 2024; 12:1323738.
PMID: 39391832
PMC: 11464430.
DOI: 10.3389/fchem.2024.1323738.
Characterization of the in vitro metabolic profile of nazartinib in HLMs using UPLC-MS/MS method: In silico metabolic lability and DEREK structural alerts screening using StarDrop software.
Attwa M, Abdelhameed A, Kadi A
Heliyon. 2024; 10(13):e34109.
PMID: 39091946
PMC: 11292529.
DOI: 10.1016/j.heliyon.2024.e34109.
In Silico and Chromatographic Methods for Analysis of Biotransformation of Prospective Neuroprotective Pyrrole-Based Hydrazone in Isolated Rat Hepatocytes.
Mateeva A, Kondeva-Burdina M, Mateev E, Nedialkov P, Lyubomirova K, Peikova L
Molecules. 2024; 29(7).
PMID: 38611754
PMC: 11013089.
DOI: 10.3390/molecules29071474.
MetSim: Integrated Programmatic Access and Pathway Management for Xenobiotic Metabolism Simulators.
Groff L, Williams A, Shah I, Patlewicz G
Chem Res Toxicol. 2024; 37(5):685-697.
PMID: 38598715
PMC: 11325951.
DOI: 10.1021/acs.chemrestox.3c00398.
Prediction of cytochrome P450-mediated bioactivation using machine learning models and in vitro validation.
Hu X, Hou Y, Teng X, Liu Y, Li Y, Li W
Arch Toxicol. 2024; 98(5):1457-1467.
PMID: 38492097
DOI: 10.1007/s00204-024-03701-w.
Chemical Catalysis Guides Structural Identification for the Major Metabolite of the BET Inhibitor JQ1.
Holmes S, Jain P, Rodriguez K, Williams J, Yu Z, Cerda-Smith C
ACS Med Chem Lett. 2024; 15(1):107-115.
PMID: 38229743
PMC: 10788937.
DOI: 10.1021/acsmedchemlett.3c00464.
DNA hypomethylation characterizes genes encoding tissue-dominant functional proteins in liver and skeletal muscle.
Maehara H, Kokaji T, Hatano A, Suzuki Y, Matsumoto M, Nakayama K
Sci Rep. 2023; 13(1):19118.
PMID: 37926704
PMC: 10625943.
DOI: 10.1038/s41598-023-46393-5.
Optimization of 3-Cyano-7-cyclopropylamino-pyrazolo[1,5-]pyrimidines toward the Development of an In Vivo Chemical Probe for CSNK2A.
Yang X, Ong H, Dickmander R, Smith J, Brown J, Tao W
ACS Omega. 2023; 8(42):39546-39561.
PMID: 37901516
PMC: 10600890.
DOI: 10.1021/acsomega.3c05377.
Evaluation of Alectinib Metabolic Stability in HLMs Using Fast LC-MS/MS Method: In Silico ADME Profile, P450 Metabolic Lability, and Toxic Alerts Screening.
Attwa M, Alrabiah H, Mostafa G, Kadi A
Pharmaceutics. 2023; 15(10).
PMID: 37896209
PMC: 10610548.
DOI: 10.3390/pharmaceutics15102449.
An Ultrafast UPLC-MS/MS Method for Characterizing the In Vitro Metabolic Stability of Acalabrutinib.
Attwa M, Bakheit A, Abdelhameed A, Kadi A
Molecules. 2023; 28(20).
PMID: 37894699
PMC: 10609012.
DOI: 10.3390/molecules28207220.
Comparison and summary of in silico prediction tools for CYP450-mediated drug metabolism.
Zhai J, Man V, Ji B, Cai L, Wang J
Drug Discov Today. 2023; 28(10):103728.
PMID: 37517604
PMC: 10543639.
DOI: 10.1016/j.drudis.2023.103728.
Strategies for translating proteomics discoveries into drug discovery for dementia.
Halder A, Drummond E
Neural Regen Res. 2023; 19(1):132-139.
PMID: 37488854
PMC: 10479849.
DOI: 10.4103/1673-5374.373681.
MetaSpot: A General Approach for Recognizing the Reactive Atoms Undergoing Metabolic Reactions Based on the MetaQSAR Database.
Mazzolari A, Perazzoni P, Sabato E, Lunghini F, Beccari A, Vistoli G
Int J Mol Sci. 2023; 24(13).
PMID: 37446241
PMC: 10341931.
DOI: 10.3390/ijms241311064.
A Robust Machine Learning Framework Built Upon Molecular Representations Predicts CYP450 Inhibition: Toward Precision in Drug Repurposing.
Ouzounis S, Panagiotopoulos V, Bafiti V, Zoumpoulakis P, Cavouras D, Kalatzis I
OMICS. 2023; 27(7):305-314.
PMID: 37406257
PMC: 10357106.
DOI: 10.1089/omi.2023.0075.
Discovery and design of dual inhibitors targeting Sphk1 and Sirt1.
Liu J, Zhao H, He L, Yu R, Kang C
J Mol Model. 2023; 29(5):141.
PMID: 37059848
DOI: 10.1007/s00894-023-05551-2.